Indivior Pharmaceuticals

INDV

Forecast & Rating4 analysts currently cover Indivior Pharmaceuticals, of which 4 give a positive rating. The average price target is $49.00, about 40.8% upside from the current price of $34.79. Coverage is limited, so the data is for reference only. Data as of Sep 14, 2026; this does not constitute investment advice.

Aug 11, 2026
Price forecast
$49.0040.85%
Forecast & RatingStrong buy
4analysts
  • Strong buy75.00%
  • Buy25.00%
  • Hold0.00%
  • Sell0.00%
  • Strong sell0.00%

Target price forecast

Forecast dateSep 14, 2026
Forecast met47.9%
Stock price$34.88
Avg. target$49.0
High target$53
Low target$43
18-month Forecast07/17/202309/14/2026

Analyst ratings

Strong buy
Buy
Hold
Sell
Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.